Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
9.27
-0.06 (-0.64%)
Nov 11, 2026, 10:46 AM EST - Market open
Keros Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Hold Maintains $16 | Hold | Maintains | $16 | +72.60% | Nov 9, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $20 | Buy | Reiterates | $20 | +115.75% | Nov 6, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $18 | Buy | Maintains | $18 | +94.17% | Sep 2, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Reiterates $20 → $17 | Hold | Reiterates | $20 → $17 | +83.39% | Aug 11, 2026 |
| William Blair | William Blair | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 4, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $30 → $23 | Buy | Maintains | $30 → $23 | +148.11% | Aug 4, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 15, 2026 |